Cargando…
Incidence of Cancer Treatment–Induced Arrhythmia Associated With Novel Targeted Chemotherapeutic Agents
BACKGROUND: The incidence of cancer treatment–induced arrhythmia (CTIA) associated with novel, targeted chemotherapeutic agents (TCAs) has not been well described. METHODS AND RESULTS: We identified all patients treated at our institution from January 2010 to December 2015 with selected TCAs. We def...
Autores principales: | Nickel, Andrew C., Patel, Akshar, Saba, Nabil F., Leon, Angel R., El‐Chami, Mikhael F., Merchant, Faisal M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474955/ https://www.ncbi.nlm.nih.gov/pubmed/30371288 http://dx.doi.org/10.1161/JAHA.118.010101 |
Ejemplares similares
-
Clinical and electrocardiographic predictors of T wave oversensing in patients with subcutaneous ICD
por: El-Chami, Mikhael F., et al.
Publicado: (2016) -
Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulators
por: Tejada, Thor, et al.
Publicado: (2017) -
Extraction of a 4-year-old leadless pacemaker with a tine-based fixation
por: Kiani, Soroosh, et al.
Publicado: (2019) -
Intermediate-term mortality and incidence of ICD therapy in octogenarians after cardiac resynchronization therapy
por: Kelli, Heval Mohamed, et al.
Publicado: (2014) -
Atrio‐ventricular synchronous pacing with a single chamber leadless pacemaker: Programming and trouble shooting for common clinical scenarios
por: El‐Chami, Mikhael F., et al.
Publicado: (2020)